How much money does Danaher make?
Andrew Walker
Updated on February 09, 2026
How much money does Danaher make?
Danaher is ranked 130th on the Fortune 500 2021….Danaher Corporation.
| Type | Public |
|---|---|
| Revenue | US$22.23 billion (2020) |
| Operating income | US$3.27 billion (2019) |
| Net income | US$2.49 billion (2017) |
| Total assets | US$46.65 billion (2017) |
Is Danaher undervalued?
Danaher Corp shows a prevailing Real Value of $332.72 per share. The current price of the firm is $319.53. At this time, the firm appears to be undervalued….332.72.
| Low | Income Per Share | High |
|---|---|---|
| 0.23 | 0.23 | 0.23 |
Who owns Danaher Corp?
Steven and Mitchell Rales, the majority stockholders of DMG, Inc., named the reorganized holding company Danaher Corporation–after a favorite mountain stream in western Montana. Steven M. Rales, 33 years old at the time, became the chief executive officer and chair of the board of the new company.
Is Danaher a good stock to buy?
Danaher has received a consensus rating of Buy. The company’s average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.
Is Danaher a good company?
Danaher is ranked 161st on the Fortune 500. In 2019, Danaher was ranked by Forbes as one of the best employers for diversity. The company is named after Danaher Creek in Western Montana. Rales and Mitchell Rales, envisioned a new kind of manufacturing company dedicated to continuous improvement.
What does Danaher stand for?
ORIGINS. Danaher takes it name from a tributary of the South Fork Flat Head River in western Montana. In the early 1980s, this was the setting for the fishing trip where Steven and Mitchell Rales envisioned a new kind of manufacturing company—one dedicated to continuous improvement and customer satisfaction.
What is the stock price of Danaher Corp?
(NYSE: DHR) Danaher Corp’s 52-week high was $261.43, and its 52-week low was $168.59. It is currently -5.36% from its 52-week high and 46.75% from its 52-week low. How much is Danaher Corp stock worth today? ( NYSE: DHR) Danaher Corp currently has 713,278,866 outstanding shares.
What is the current short interest in Danaher?
The most recent short interest data has been released by the NASDAQ for the 12/15/2015 settlement date, which shows a 1,223,292 share decrease in total short interest for Danaher Corp. (NYSE: DHR), to 9,457,505, a decrease of 11.45% since 11/30/2015. Total short interest is just one way to look at […]
When did Danaher announce its intention to purchase the business?
Danaher announced its intent to purchase the business in February 2019, and the deal necessitated regulatory approvals in several countries and a substantial stock sale to finance the acquisition. Danaher (DHR) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Who is the Chief Scientific Officer of Danaher?
Sources: Factset, Bloomberg, S&P Cap IQ; Forbes. See how Jose-Carlos Gutierrez-Ramos, the new Chief Scientific Officer of Danaher, is working to break industry bottlenecks and bring biopharma innovation into the post-Covid era. With 40% Gains This Year, Has Danaher Stock Reached Its Potential?
What is the stock price of Danaher Corporation?
Danaher (DHR) provides an update on first-quarter 2020 results and withdraws its earlier announced guidance for 2020 on the impacts of the coronavirus outbreak. General Electric Co said on Monday it used part of the $20 billion in proceeds from the sale of its biopharma business to cut debt.
The most recent short interest data has been released by the NASDAQ for the 12/15/2015 settlement date, which shows a 1,223,292 share decrease in total short interest for Danaher Corp. (NYSE: DHR), to 9,457,505, a decrease of 11.45% since 11/30/2015. Total short interest is just one way to look at […]
Danaher announced its intent to purchase the business in February 2019, and the deal necessitated regulatory approvals in several countries and a substantial stock sale to finance the acquisition. Danaher (DHR) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Sources: Factset, Bloomberg, S&P Cap IQ; Forbes. See how Jose-Carlos Gutierrez-Ramos, the new Chief Scientific Officer of Danaher, is working to break industry bottlenecks and bring biopharma innovation into the post-Covid era. With 40% Gains This Year, Has Danaher Stock Reached Its Potential?
